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A C C E P T E D M
A N U S C R I P T verified that the 1,25(OH)2D-induced responses were present. RNAScope revealed that the mRNA response present after six hours is limited to mature enterocytes exposed to the intestinal lumen in both the duodenum and colon. No detectable expression was observed in goblet cells, lamina propria, muscularis mucosa muscle, submucosa and submucosal lymphoid follicles, or tunica muscularis. Our findings have identified epithelial enterocytes to be the intestinal targets for 1,25(OH)2D in both the duodenum and colon. differentiation, and inflammation [1, 2] . In the intestines, 1,25(OH)2D increases the uptake of dietary calcium, but the localization of the mRNA response within the tissue architecture has not been confirmed.
In the mouse, both the duodenum and colon respond to orally administered 1,25(OH)2D [1] . The colon, however, requires larger doses to surpass the small intestine. These larger doses of 1,25(OH)2D inadvertently perturb systemic 1,25(OH)2D and may cause deleterious effects. To eliminate potential complications, our laboratory previously synthesized a therapeutic glucuronide of 1,25(OH)2D, β-glucuronic-1,25(OH)2D (β-G-1,25(OH)2D) [3] . Conjugation with a glucuronic acid moiety via betalinkage renders the β-G-1,25(OH)2D molecule inaccessible to mammalian digestive enzymes. When
ingested, the glucuronide moiety remains intact through the small intestine until arriving in the colon.
There bacterial glucuronidases in the colon hydrolyze the beta-linked acid and liberate 1,25(OH)2D.
Thus, β-G-1,25(OH)2D pharmacologically delivers 1,25(OH)2D to the colon for hormonal action [3, 4] .
Activation of VDR by 1,25(OH)2D-binding induces expression of an array of genes containing vitamin D response elements (VDREs) [5] . One particular gene, cytochrome P450 family 24 subfamily A member 1 (Cyp24a1), encodes for the 24-hydroxlase that initiates degradation of 1,25(OH)2D in a negative feedback manner [6] . The promoter region of this gene contains two VDREs and, consequently, is robust and sensitive to the actions of ligand-bound VDR [7] . Thus, increased In the RNAScope assay by Advanced Cell Diagnostics (Newark, CA), hybridizations between modified DNA probes and the complementing target mRNA undergo an amplification that enhances sensitivity with minimal background detection [12] . In the following study, we use RNAScope to assess the induction of Cyp24a1 mRNA by 1,25(OH)2D in both the duodenum and colon of mice to confirm the hypothesis that the 1,25(OH)2D-response occurs in the epithelial cells of the intestine.
Methods

Animals
Twenty-one adult male CD1 mice were obtained from Jackson Laboratories (Bar Harbor, ME).
Mice were housed in groups and fed a standard diet (Teklad 2018, Madison, WI) ad libitum, with unlimited access to food and water in a 12-hour light/dark cycle. Rodent care and handling procedures were approved by the Iowa State University Institutional Animal Care and Use Committee.
Animal experiments
1,25-Dihydroxyvitamin D3 was purchased from Sigma Aldrich (St. Louis, MO), and β-G-1,25(OH)2D was synthesized by methods previously described [3] . Compounds were dissolved in 100% 
RNA extraction
Total RNA was extracted from TRIzol homogenates. RNA was solubilized by using the recommended chloroform separation per TRIzol reagent protocol (Invitrogen, Carlsbad, CA). The upper
aqueous phase was removed and subjected to RNeasy mini prep column (Qiagen, Germantown, MD).
Total RNA extraction was performed as recommended with an added wash (2 M NaCl and 2 mM EDTA at pH 4.0) as previously described [4] . Columns were eluted with 50 μL nuclease-free water and the total RNA concentration determined by using the absorbance at 260 nm wavelength. RNA quality was verified with 260:280 nm of approximately 2.0. Samples were diluted to 0.5 μg total RNA/uL of nuclease-free water. cDNA was synthesized from 1 μg of RNA by using random hexamer primers and SuperScript III First Strand Synthesis (Invitrogen, Carlsbad, CA). cDNA samples were diluted to a final volume of 100 μL with Tris-EDTA buffer (10 mM Tris and 1 mM EDTA) and stored at -20 o C for analysis by QRT-PCR.
QRT-PCR analysis
QRT-PCR was performed on an Mx3005p thermal cycler by Stratagene (La Jolla, CA). cDNA relative to the Ct of Gapdh (dCt) and normalized to the average dCt of control animals (ddCt).
RNAScope in situ hybridization
Paraffin-embedded tissues were cut to 5 μm sections by using a rotary microtome. Immediately following sectioning, RNA ISH was completed per RNAScope 2.0 HD Red Manual Detection Kit protocol with pretreatment optimization (Advanced Cell Diagnostics, Newark, CA). Positive (Mus peptidylprolyl isomerase B) and negative (E. coli dihydrodipicolinate reductase) oligo probes were used as procedural controls. Oligo probes for murine Cyp24a1 were custom designed and are proprietary to
Advanced Cell Diagnostics. Hybridization of probes to the mRNA and amplification of the hybridizations were performed per protocol and detected by using Fast Red chromogenic dye with hematoxylin counterstain of the tissue. mRNA signal particles were counted by using ImageJ software (US NIH, Besthesda, MD) with a Colour Deconvolution plug-in. Particle signal was counted if the particle size was within 4 to 50 pixels in diameter and at least 0.8 circularity. Particle count was determined as the average of five fields from each section observed at 40x magnification.
Statistical analysis
Data were analyzed by using the GLM procedure for ANOVA comparisons with Tukey-Kramer adjustments for multiple comparisons and the REG procedure for correlations in SAS statistical software (SAS Institute Inc, Cary, NC). 2C ). In the colons, the effects of all β-G-1,25(OH)2D doses were statistically greater than those of controls (P< 0.05), but not different from one another (Fig. 2D) , suggesting a maximal threshold was met with 6 pmol β-G-1,25(OH)2D. The lack of duodenal stimulation by β-G-1,25(OH)2D indicates that the glucuronide-bound complex delivers no hormonal stimulation and further supports the assumption that β-G-1,25(OH)2D is biologically inactive until glucuronide hydrolysis by bacterial enzymes [3, 4] .
Results
Appearance of 1,25(OH)2D into blood plasma
QRT-PCR from crude tissue homogenates
RNAScope in situ hybridization of 1,25(OH)2D-stimulated intestines
RNAScope hybridizations were performed with mus Cyp24a1 probes to locate 1,25(OH)2D-dependent responses in duodenal and colon tissues. This assay amplifies the mRNA:probe hybridizations in tissue sections for visualization under light microscopy. Cyp24a1 mRNA was observed in all 1,25(OH)2D-treated duodena and β-G-1,25(OH)2D-treated colons, whereas the duodena and colons from control animals had no visible expression (Fig. 3) . Quantitative analysis of the RNAScope hybridization was performed in ImageJ software. The images were filtered by using the Colour Deconvolution plug-in to isolate the Fast Red chromogenic color. Once filtered, a particle count was performed as described in section 2.5. The 24 pmol dose of 1,25(OH)2D yielded an average particle count for the duodenum that was significantly greater than for the control duodenum, but not statistically different among other doses of 1,25(OH)2D. No statistical differences were observed in the colons across all doses of β-G-1,25(OH)2D, despite significant increases observed by QRT-PCR (Fig. 4B ). An inability to distinguish individual mRNA signals at high abundance may have interfered with particle count determination and caused a high degree of variation in the measurement. Variation in particle count may also be affected by the random selection of fields obtained, the sensitivity of the optics and analysis software, and/or the orientation of the tissue when paraffin-embedded. We then compared the RNAScope Cyp24a1 particle count with the corresponding QRT-PCR Cyp24a1 mRNA ddCt for each animal (Fig. 4C, D) . By using Pearson's R (ρ) statistical method, we observed significant positive correlations between QRT-PCR and particle count for both tissues (P < 0.05).
Discussion
As a steroid hormone, 1,25(OH)2D targets cells in the intestine to increase the mRNA expression of proteins vital for adequate calcium absorption. Through the use of RNAScope ISH, we observed that the 1,25(OH)2D-mediated mRNA response is distinctly limited to enterocytes in both the duodenum and colon of mice 6 hours after treatment (Fig. 3) . Furthermore, the mRNA expression is most abundant in enterocytes of the duodenal villi and colonic tips rather than in crypt regions. These been shown in human plasma and bile [14, 15] . Future research will be needed to clarify the role for bile and vitamin D glucuronides in the 1,25(OH)2D-mediated activity of the intestinal epithelium.
In conclusion, we have confirmed that the intestinal 1,25(OH)2D-mediated response occurs in enterocytes at the villi of the duodenum and the tips of the colon by in situ observation of 1,25(OH)2D-stimulated mRNA. These data correspond with previous work using protein immunohistochemistry.
Lastly, we noted a lack of stimulation in the duodenum despite increased plasma [1,25(OH)2D] and considered the possibility that the location of the response may indicate a physiological mechanism of enterohepatic signaling for 1,25(OH)2.
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